These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 36005828)

  • 21. Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes.
    Aili Y; Maimaitiming N; Mahemuti Y; Qin H; Wang Y; Wang Z
    Am J Cancer Res; 2020; 10(12):4134-4150. PubMed ID: 33414991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
    Muinelo-Romay L; Casas-Arozamena C; Abal M
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
    Hicks JK; Saller J; Wang E; Boyle T; Gray JE
    Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges.
    Rijavec E; Coco S; Genova C; Rossi G; Longo L; Grossi F
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
    Tuaeva NO; Falzone L; Porozov YB; Nosyrev AE; Trukhan VM; Kovatsi L; Spandidos DA; Drakoulis N; Kalogeraki A; Mamoulakis C; Tzanakakis G; Libra M; Tsatsakis A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update.
    Kapeleris J; Ebrahimi Warkiani M; Kulasinghe A; Vela I; Kenny L; Ladwa R; O'Byrne K; Punyadeera C
    Front Oncol; 2022; 12():859152. PubMed ID: 35372000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer.
    Pesta M; Shetti D; Kulda V; Knizkova T; Houfkova K; Bagheri MS; Svaton M; Polivka J
    Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.
    Marrugo-Ramírez J; Mir M; Samitier J
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
    Mathai RA; Vidya RVS; Reddy BS; Thomas L; Udupa K; Kolesar J; Rao M
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30889786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Tumor DNA in Pediatric Cancer.
    Doculara L; Trahair TN; Bayat N; Lock RB
    Front Mol Biosci; 2022; 9():885597. PubMed ID: 35647029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation.
    Carvalho Â; Ferreira G; Seixas D; Guimarães-Teixeira C; Henrique R; Monteiro FJ; Jerónimo C
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.
    Calandri M; Siravegna G; Yevich SM; Stranieri G; Gazzera C; Kopetz S; Fonio P; Gupta S; Bardelli A; Veltri A; Odisio BC
    Eur Radiol; 2020 Aug; 30(8):4496-4503. PubMed ID: 32193642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Droplet Digital PCR Analysis of Liquid Biopsy Samples Unveils the Diagnostic Role of hsa-miR-133a-3p and hsa-miR-375-3p in Oral Cancer.
    Crimi S; Falzone L; Gattuso G; Grillo CM; Candido S; Bianchi A; Libra M
    Biology (Basel); 2020 Nov; 9(11):. PubMed ID: 33172167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using Liquid Biopsy in the Treatment of Patient with OS.
    Shulman DS; Crompton BD
    Adv Exp Med Biol; 2020; 1257():95-105. PubMed ID: 32483734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.